MedPath

Does combination of metformin together with myoinositol and D-chiroinositol improve clinical, metabolic and hormonal parameters in women with polycystic ovaries

Not Applicable
Conditions
Health Condition 1: null- Polycystic Ovarian Syndrome
Registration Number
CTRI/2018/05/013977
Lead Sponsor
AIIMS Rishikesh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Women in the reproductive age group with Polycystic ovarian syndrome (PCOS), according to Rotterdam criteria

2.Willing to participate in study and follow up

Exclusion Criteria

•Patient already on other drugs for treatment of PCOS like Oral Contraceptive Pills

•Deranged kidney or liver function tests

•Uncontrolled Thyroid disorders or Hyperprolactinemia

•Known hypersensitivity to metformin or myoinositol/ D-Chiro-inositol

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath